Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort.

Millie Beament; Katharine Wiltshire; Christopher R S Belder; Emily Abel; Melanie Hart; Amanda J Heslegrave; Michael P Lunn; Miguel Rosa-Grilo; Owen Swann; Jonathan M Schott; Henrik Zetterberg; Nick C Fox; Ashvini Keshavan

doi:10.1186/s13195-026-02180-8

SCHEDA SCIENTIFICA2026Studio osservazionale

Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort.

Millie Beament, Katharine Wiltshire, Christopher R S Belder, Emily Abel, Melanie Hart, Amanda J Heslegrave, Michael P Lunn, Miguel Rosa-Grilo, Owen Swann, Jonathan M Schott, Henrik Zetterberg, Nick C Fox, Ashvini Keshavan

Alzheimer's research & therapy · 2026

Psicologia clinica Psicodiagnostica

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansAlzheimer DiseaseBiomarkersFemaleReproducibility of ResultsMaletau ProteinsAgedAmyloid beta-PeptidesCohort StudiesAged, 80 and overPeptide FragmentsGlial Fibrillary Acidic ProteinAlzheimer’s diseaseBlood-based biomarkersPhosphorylated tau-217Test-retest reliability

Come citare questo studio

Millie Beament, Katharine Wiltshire, Christopher R S Belder, Emily Abel, Melanie Hart, Amanda J Heslegrave, Michael P Lunn, Miguel Rosa-Grilo, Owen Swann, Jonathan M Schott, Henrik Zetterberg, Nick C Fox, Ashvini Keshavan. (2026). Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort.. Alzheimer's research & therapy. DOI: 10.1186/s13195-026-02180-8

Consulta la pubblicazione originale ↗